RAD December 2023 Abstracts and Posters
All accepted abstracts will be published in The British Journal of Dermatology.526 - Efficacy of Upadacitinib vs Dupilumab for Moderate-to-Severe Atopic Dermatitis: Analysis of Time Spent in Itch Response State from the Heads Up Study
Andrew Blauvelt; Marjolein de Bruin-Weller; Shawn G Kwatra; Melinda J Gooderham; Brian Kim; Yingyi Liu; Alvina D Chu; Sarah Ofori; Andrew Platt; Brian M Calimlim; Jonathan I Silverberg
527 - Efficacy of upadacitinib for moderate-to-severe atopic dermatitis: Analysis of time spent in skin clearance response states from the Measure Up 1, Measure Up 2, and Heads Up studies
Andrew Blauvelt, Brian M Calimlim, Yingyi Liu, Andrew Platt, Jonathan I Silverberg
528 - Rapid skin clearance and itch improvement with upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: Results from a phase 3b head-to-head clinical trial (Heads Up)
Eric L Simpson, Antonio Costanzo, Vimal H Prajapati, Brian M Calimlim, Alvina D Chu, Tianshuang Wu, Kilian Eyerich
529 - Worsening of itch before flaring in patients with moderate-to-severe atopic dermatitis treated with abrocitinib: a post hoc analysis of the phase 3 JADE REGIMEN trial
Jonathan I. Silverberg, Brian S. Kim, Marjolein de Bruin-Weller, Stephan Weidinger, Martin Steinhoff, Pinaki Biswas, Urs Kerkmann, Claire Feeney, Herwig Koppensteiner
530 - Treatment efficacy in patients with moderate-to-severe atopic dermatitis who switched from dupilumab to abrocitinib in JADE EXTEND, a phase 3 long-term extension study
Melinda J. Gooderham, Stephan Weidinger, Eric L. Simpson, Mette Deleuran, Linda F. Stein Gold, Saleem A. Farooqui, Pinaki Biswas, Gary Chan, Erman Güler, Herwig Koppensteiner
531 - Physician-assessed effectiveness and patient-reported outcomes in adult and adolescent patients with atopic dermatitis treated with dupilumab: real-world insights 1 year into the GLOBOSTAD multinational prospective observational study
Silvia M. Ferrucci, Piergiacomo Calzavara-Pinton, Dédée F. Murrell, Anne-Claire Fougerousse, Iva Karlova, Hilde Lapeere, Gregor Holzer, Mona Al-Ahmad, Chia-Yu Chu, Caterina Foti, Bibiana Pérez-García, Jiangming Wu, Marius Ardeleanu, Kwinten Bosman
533 - Long-term 5-year safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis including over 7000 patient-years of exposure
Christopher Bunick, Raj Chovatiya, Emma Guttman, Mona Shahriari, Mark Boguniewicz, Xinghua Gao, Justin Greiwe, Andrew Blauvelt, Marie LA Schuttelaar, Alan D. Irvine, Gweneth F Levy, Andrew Platt, Deanne Dilley, Henrique Teixeira, Katherine Altman, Ayman Grada, Jonathan Silverberg
534 - Incidence of venous thromboembolic events and atherosclerotic cardiovascular disease risk factors in adolescents and adults with atopic dermatitis in Denmark: a population-based cohort study
Alexander Egeberg, Andreas Wollenberg, Thomas Bieber, Adina R. Lemeshow, Shefali Vyas
535 - Exploring the Intersectionality of Being Deaf and Black while Accessing Dermatological Care
Diamond Guy BS and Jason M. Rotoli MD
538 - Physician-assessed effectiveness and patient-reported outcomes in adult and adolescent patients with atopic dermatitis in the Asian subpopulation treated with dupilumab: real-world insights 1 year into the GLOBOSTAD multinational prospective observational study
Wen-Hung Chung, Yoko Kataoka, Chia-Yu Chu, Shintaro Takeoka, Chih-Hung Lee, Yayoi Tada, Po-Ju Lai, Hidetoshi Takahashi, Akiko Yagami, Jiangming Wu, Marius Ardeleanu, Kwinten Bosman